FindTrial
Sign In

Transforaminal Lumbar Endoscopic Discectomy versus Coblation Nucleoplasty combined with Collagenase Chemonucleolysis for Lumbar Disc Herniation with Grade I Degenerative Spondylolisthesis

Transforaminal Lumbar Endoscopic Discectomy versus Coblation Nucleoplasty combined with Collagenase Chemonucleolysis for Lumbar Disc Herniation with Grade I Degenerative Spondylolisthesis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300076809
Enrollment
Unknown
Registered
2023-10-19
Start date
2023-05-01
Completion date
Unknown
Last updated
2023-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar Disc Herniation

Interventions

TLED group:N/A
CN combined with CCNL group:N/A

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
33 Years to 88 Years

Inclusion criteria

Inclusion criteria: ? Lumbar disc herniation was diagnosed according to imaging and clinical manifestations; ? Lumbar spondylolisthesis I; ? Conservative treatment for 3 months or more was ineffective.

Exclusion criteria

Exclusion criteria: ? Patients with recurrence of lumbar disc herniation; ? Patients with lumbar spondylolisthesis of second degree or above; ?Patients with puncture site infection, hemorrhagic disease or abnormal coagulation function, and those who can not understand the visual analogue scale.

Design outcomes

Primary

MeasureTime frame
VAS;ODI;—

Secondary

MeasureTime frame
QoR-15;MacNab;—

Countries

China

Contacts

Public ContactWang Likui

The First Affiliated Hospital of Anhui Medical University

wlk9560@163.com+86 137 0569 0702

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026